Vice President, Head of Quantitative and Clinical Pharmacology
DSI
Malaz A AbuTarif is the Vice President and Global Head of the Quantitative and Clinical Pharmacology Department at Daiichi-Sankyo Inc with over 70 scientists in the department globally. He has over 20 years of post-doctoral Clinical Pharmacology and Pharmacometric experience in the Pharmaceutical Industry. Malaz is a Pharmacist by training and then obtained his PhD in Pharmaceutics with specialty in PKPD and research focused on Clinical Pharmacology and Modeling and Simulation. He Started his post-doctoral industry career at J&J Pharmaceutical R&D and has had increasing responsibilities throughout his career in Schering-Plough Research Institute, Bristol Myers Squibb and Daichi-Sankyo Inc.
Disclosure information not submitted.
Keynote: ADC: Drug Development Challenges- What We are Measuring and What Does it Matter?
Tuesday, October 22, 2024
1:30 PM – 2:30 PM MT